BlackRock Amends Prothena Stake, Maintains Passive Investment
Ticker: PRTA · Form: SC 13G/A · Filed: Feb 2, 2024 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | SC 13G/A |
| Filed Date | Feb 2, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still owns Prothena stock, signaling passive confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on February 2, 2024, disclosing its ownership of Prothena Corporation Public Limited Company's Common Stock as of December 31, 2023. This filing, Amendment No. 9, indicates BlackRock's continued passive investment in Prothena, a pharmaceutical preparations company. This matters to investors because BlackRock is a major institutional investor, and its sustained, albeit passive, stake can signal confidence in Prothena's long-term prospects, potentially influencing other investors.
Why It Matters
This filing confirms BlackRock's ongoing significant, yet passive, ownership in Prothena, which can be interpreted as a vote of confidence from a major institutional investor.
Risk Assessment
Risk Level: low — This is a routine amendment from a passive institutional investor, indicating no immediate change in investment strategy or significant risk.
Analyst Insight
A smart investor would note BlackRock's continued passive stake as a sign of institutional stability, but would not interpret it as an immediate buy or sell signal without further analysis of Prothena's fundamentals and BlackRock's specific ownership percentage (which is not detailed in this excerpt).
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Prothena Corporation Public Limited Company (company) — the issuer whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- February 2, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 9 (number) — the specific amendment number of the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9)' sections.
Who is the reporting person in this filing?
The reporting person, or the entity that filed this document, is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What is the subject company whose securities are being reported?
The subject company, or the issuer, is PROTHENA CORP PUBLIC LTD CO (Prothena Corporation Public Limited Company), as stated in the 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PROTHENA CORP PUBLIC LTD CO' section.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as explicitly stated in the filing.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the '[X] Rule 13d-1(b)' checkbox selection in the document.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 2, 2024 regarding PROTHENA CORP PUBLIC LTD CO (PRTA).